- Home
- CTO vs ABSI Comparison
CTO vs ABSI Comparison
Compare CTO & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTO
- ABSI
- Stock Information
- Founded
- CTO 1902
- ABSI 2011
- Country
- CTO United States
- ABSI United States
- Employees
- CTO N/A
- ABSI N/A
- Industry
- CTO Real Estate Investment Trusts
- ABSI Biotechnology: Pharmaceutical Preparations
- Sector
- CTO Real Estate
- ABSI Health Care
- Exchange
- CTO Nasdaq
- ABSI Nasdaq
- Market Cap
- CTO 552.9M
- ABSI 505.4M
- IPO Year
- CTO N/A
- ABSI 2021
- Fundamental
- Price
- CTO $17.94
- ABSI $3.04
- Analyst Decision
- CTO Strong Buy
- ABSI Strong Buy
- Analyst Count
- CTO 3
- ABSI 6
- Target Price
- CTO $22.00
- ABSI $7.78
- AVG Volume (30 Days)
- CTO 268.8K
- ABSI 4.7M
- Earning Date
- CTO 10-28-2025
- ABSI 11-12-2025
- Dividend Yield
- CTO 8.47%
- ABSI N/A
- EPS Growth
- CTO N/A
- ABSI N/A
- EPS
- CTO N/A
- ABSI N/A
- Revenue
- CTO $146,948,000.00
- ABSI $2,815,000.00
- Revenue This Year
- CTO $20.84
- ABSI $40.12
- Revenue Next Year
- CTO $6.72
- ABSI $331.37
- P/E Ratio
- CTO N/A
- ABSI N/A
- Revenue Growth
- CTO 23.84
- ABSI N/A
- 52 Week Low
- CTO $15.07
- ABSI $2.01
- 52 Week High
- CTO $20.88
- ABSI $6.33
- Technical
- Relative Strength Index (RSI)
- CTO 69.96
- ABSI 42.40
- Support Level
- CTO $17.02
- ABSI $2.71
- Resistance Level
- CTO $17.55
- ABSI $3.11
- Average True Range (ATR)
- CTO 0.29
- ABSI 0.26
- MACD
- CTO 0.03
- ABSI -0.04
- Stochastic Oscillator
- CTO 91.03
- ABSI 37.60
About CTO CTO Realty Growth Inc.
CTO Realty Growth Inc is a real estate investment trust company, that owns income properties comprised of approximately 2.7 million square feet in diversified markets in the United States. Its portfolio of assets consists of Income Properties Portfolio, management services, Commercial Loan and Investments.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.